| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.12.25 | OUE HEALTHCARE LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::CESSATION OF SHAREHOLDING BY SUBSTANTIAL SHAREHOLDER | 2 | SGX Company Announcements | ||
| OUE HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 24.12.25 | OUE HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS AND THE NOMINATING AND REMUNERATION COMMITTEE | 2 | SGX Company Announcements | ||
| 24.12.25 | OUE HEALTHCARE LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::RESIGNATION OF NON-INDEPENDENT AND NON-EXECUTIVE DIRECTOR | 1 | SGX Company Announcements | ||
| 17.12.25 | OUE HEALTHCARE LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER | 1 | SGX Company Announcements | ||
| 16.12.25 | OUE HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::CESSATION OF SHAREHOLDING BY BROWNY HEALTHCARE PTE. LTD. | 1 | SGX Company Announcements | ||
| 25.11.25 | OUE HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::DISCLOSURES PURSUANT TO RULES 704(33) AND 728 OF THE CATALIST RULES | 1 | SGX Company Announcements | ||
| 15.09.25 | OUE HEALTHCARE LIMITED: GENERAL ANNOUNCEMENT::DISCLOSURES PURSUANT TO RULES 704(33) AND 728 OF THE CATALIST RULES | 1 | SGX Company Announcements | ||
| 13.08.25 | OUE HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | - | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,150 | 0,00 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Der Aktienkurs der Münchner spiegle die mittelfristigen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,890 | 0,00 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,990 | 0,00 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Nach einem Unternehmenskontakt verglich Analyst David... ► Artikel lesen | |
| PROGYNY | 23,240 | -4,01 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,030 | -3,61 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,560 | 0,00 % | Silber bald bei 200 USD? Teuer einkaufen oder Chance nutzen bei CSG, American Atomics und Carl Zeiss Meditec | Nach einem nervösen Jahresstart rücken Rohstoffe und Energiefragen wieder klar in den Fokus der Kapitalmärkte. Die jüngsten Diskussionen um Handelszölle und geopolitische Abhängigkeiten, die auch das... ► Artikel lesen | |
| HEARTFLOW | 28,370 | 0,00 % | Heartflow: Wells Fargo startet Coverage mit "Overweight" und Kursziel von 38 $ | ||
| GENEDX | 95,16 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 22,890 | 0,00 % | Alignment Healthcare (ALHC) Drops 12% on Medicare Flat Funding | ||
| PROCEPT BIOROBOTICS | 29,200 | +0,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 25,120 | 0,00 % | Carl Zeiss Meditec, Fuchs, Gerresheimer, Hensoldt, Lanxess, Renk: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| LUMEXA IMAGING | 11,800 | -3,75 % | Lumexa Imaging's Dr. Kemp elected to RSNA board | ||
| BETA BIONICS | 14,460 | +5,55 % | Beta Bionics: TD Cowen bleibt trotz FDA-Warnung bei "Hold"-Einstufung | ||
| AVEANNA HEALTHCARE | 8,470 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| BILLIONTOONE | 82,81 | -0,90 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |